புதியது ப்ராடக்ட்ஸ் மற்றும் சேவைகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from புதியது ப்ராடக்ட்ஸ் மற்றும் சேவைகள். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In புதியது ப்ராடக்ட்ஸ் மற்றும் சேவைகள் Today - Breaking & Trending Today

FDA weighs approval of a lucrative Alzheimer's drug but benefits are iffy | Nation/World

The Food and Drug Administration’s decision next week whether to approve the first treatment for Alzheimer’s disease highlights a deep division over the drug’s benefits as well as criticism about ....

United States , United Kingdom , Vanderbilt University , Leslie Norins , Janet Woodcock , Samuell Jackson , Peter Lurie , Matthew Schrag , Joanne Pike , Billy Dunn , Human Services , Drug Administration , Kaiser Family Foundation , Tribune Content Agency , Office Of Neuroscience , Kaiser Health News , Department Of Health , Alzheimer Association , Public Citizen Health Research Group , Public Interest , Germ Quest , Sarah Riley Saint , Policy Analysis , New Products And Services , Product Approvals , Drug Approvals ,

Baidu begins charging customers for driverless taxi service

SHARE
Chinese tech giant Baidu rolled out its paid driverless taxi service on Sunday, making it the first company to commercialise autonomous driving operations in China.
Unlike previous Baidu autonomous driving demonstrations in Beijing, this was the first time there was no safety driver sitting behind the wheel. Instead, a safety member sits in the front passenger seat to deal with any emergencies.
Up to 10 Apollo “robotaxis” are now operating simultaneously in an area of about 3 square kilometres, picking up and dropping off passengers at eight stops around Shougang Park in western Beijing. Each ride costs 30 yuan ($4.60), and is open to passengers aged 18 to 60. ....

Kelly Wang , Amy Li , Baidu Apollo , Shougang Park , Greater China , East Asia , Search Technology , Computing And Information Technology , New Products And Services , Products And Services , Corporate News , Driverless Cars , Automotive Technology , Industrial Technology , Transportation Safety , Associated Press , Special Pages , கெல்லி வாங் , ஆமி லி , பைடு அப்பல்லோ , அதிகமானது சீனா , கிழக்கு ஆசியா , தேடல் தொழில்நுட்பம் , கணினி மற்றும் தகவல் தொழில்நுட்பம் , புதியது ப்ராடக்ட்ஸ் மற்றும் சேவைகள் , ப்ராடக்ட்ஸ் மற்றும் சேவைகள் ,

FPT Software Joins Hands with Mitsui to Boost Cybersecurity in Japan

Press release content from Business Wire. The AP news staff was not involved in its creation.
FPT Software Joins Hands with Mitsui to Boost Cybersecurity in Japan
April 20, 2021 GMT
FPT Software Chairman Ms. Ha and Mitsui IT & Communication Business Unit GM Mr. Kogiku at the signing ceremony in February 2021. (Photo: Business Wire)
FPT Software Chairman Ms. Ha and Mitsui IT & Communication Business Unit GM Mr. Kogiku at the signing ceremony in February 2021. (Photo: Business Wire)
HANOI, Vietnam (BUSINESS WIRE) Apr 20, 2021
Vietnam’s leading IT services provider FPT Software has announced its partnership with conglomerate Mitsui & Co., (Mitsui), looking to tap into growing demands for cybersecurity in the Japanese market. ....

Han I , Republic Of , Corporate Development Business , Mitsui Co , Business Wire , Chairman Chu Thanh , Asia Pacific , Fortune Global , Steel Products , Metal Resources , Infrastructure Projects , Retail Management , Corporate Development , Sao Mai , Global Marketing , Corporate News , Products And Services , Software Industry , Information Technology , New Products And Services , Southeast Asia , East Asia , Computing And Information Technology , ஹான் நான் , குடியரசு ஆஃப் , பெருநிறுவன வளர்ச்சி வணிக ,

Santhera Reports Interim Results on Convertible Bond Exchange Offer

Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Santhera Reports Interim Results on Convertible Bond Exchange Offer
Santhera Pharmaceuticals Holding AGApril 20, 2021 GMT
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN ANY JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO
Pratteln, Switzerland, April 20, 2021 – Santhera Pharmaceuticals (SIX: SANN) announces that so far an aggregate principal value of around CHF 39.6 million, or 66% of its CHF 60 Million Convertible Bonds, have been accepted for exchange under the Exchange Offer announced on March 25, 2021. Bondholders who have not yet accepted the Exchange Offer will be able to do so during the additional acceptance period ending on April 27, 2021, 5:00 p.m. CEST. In parallel to the Exchange Offer, voting on the bondholders’ resolution continues. ....

Switzerland General , United States , United Kingdom , Eva Kalias , Santhera Pharmaceuticals , Neither The Company , Swiss Financial Services Act Fin , Head External Communications , Notice The Exchange , Financial Services , Santhera Pharmaceuticals Holding , Us Securities Exchange , Stifel Nicolaus Europe , European Union Withdrawal , Chiesi Group , Highbridge Tactical Credit Master Fund , Convertible Bonds , Exchange Offer , Repurchase Offer , Tactical Credit Master Fund , Nicolaus Europe Limited , Unsecured Convertible Bonds , Listing Prospectus Regarding , New Bonds , Bondholder Meeting , Annual Report ,

ERYTECH Requested a Pre-BLA Meeting with the FDA to Discuss Path to Approval in ALL

Press release content from Globe Newswire. The AP news staff was not involved in its creation.
ERYTECH Requested a Pre-BLA Meeting with the FDA to Discuss Path to Approval in ALL
Erytech Pharma S.A.April 20, 2021 GMT
ERYTECH Requested a Pre-BLA Meeting with the FDA
to Discuss Path to Approval in ALL
ERYTECH invited by FDA to request a pre-BLA meeting
First step in the marketing approval process with the FDA for eryaspase for the treatment of hypersensitive ALL patients based on the positive results of the NOPHO-sponsored Phase 2 clinical trial
Lyon (France) and Cambridge, MA (U.S.), April 20, 2021 – ERYTECH Pharma (Nasdaq & Euronext: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, today announced the initiation of the process of seeking marketing approval from the U.S. Food and Drug Administration (US FDA) for its lead product candidate eryaspase i ....

United States , United Kingdom , France General , New Jersey , Mathilde Bohin , Louis Victor Delouvrier , Nicolas Merigeau , Corey Davis , Enregistrement Universel , Pharma Bio , Eric Soyer , Lifesci Advisors , Company Securities , Drug Administration , Exchange Commission , Company Annual Report On Form , Nordic Society Of Pediatric Hematology , Discuss Path , Biologics License Application , Nordic Society , Pediatric Hematology , Nasdaq Global Select Market , Next Biotech , French Autorit , Des March , Annual Report ,